Explore 74 practical articles about prostate cancer awareness, risk, screening, diagnosis, treatment, and life beyond cancer. Find answers by topic or search for what matters to you.
Search by keyword, browse by topic, or open any article for a full explanation and source link.
The American Cancer Society estimates 333,830 new prostate cancer diagnoses and 36,320 deaths in the United States in 2026. These estimates describe a major public-health burden, not any one person's likelihood of developing cancer.
Read article →Prostate cancer is one of the most commonly diagnosed cancers among men in the United States. Awareness campaigns help people learn about risk, screening tradeoffs, symptoms, and where to seek credible information.
Read article →The American Cancer Society estimates that about one in eight men will be diagnosed with prostate cancer during their lifetime. Age, family history, ancestry, and inherited variants can change individual risk.
Read article →Prostate cancer becomes more common as people age. Many diagnoses occur after age 65, although individual risk varies and screening decisions depend on overall health as well as age.
Read article →Black men in the United States face higher prostate cancer incidence and mortality. Researchers and advocates point to a combination of biological, structural, and access-related factors, and no single explanation accounts for the disparity.
Read article →A father, brother, or son with prostate cancer may affect your risk, especially when relatives were diagnosed at younger ages or multiple relatives were affected. Details on both sides of the family can be relevant.
Read article →Certain inherited changes, including some BRCA2 variants, can increase prostate cancer risk. Genetic testing is not appropriate for everyone and should be guided by personal and family history.
Read article →BRCA1 and BRCA2 are often discussed in relation to breast and ovarian cancer, but some inherited variants also matter for prostate cancer risk and treatment decisions.
Read article →The prostate is a gland in the male reproductive system located below the bladder and in front of the rectum. It contributes fluid to semen and surrounds part of the urethra.
Read article →Prostate cancer begins when cells in the prostate develop changes that allow abnormal growth. Many tumors grow slowly, while some are more aggressive and require prompt assessment.
Read article →Localized prostate cancer often causes no noticeable symptoms. Symptoms alone cannot reliably confirm or rule out cancer, which is why discussions about risk and testing matter.
Read article →Difficulty starting urination, a weak stream, or frequent urination can have many causes, including benign prostate enlargement and infection. Symptoms need evaluation but do not automatically indicate cancer.
Read article →Blood in urine may have causes unrelated to prostate cancer, including infection, stones, or other urinary tract conditions. It deserves medical evaluation rather than self-diagnosis.
Read article →Prostate cancer that spreads to bones can cause pain, but most bone pain is not cancer. New persistent pain, especially with a known cancer diagnosis, warrants evaluation.
Read article →The prostate-specific antigen blood test measures a protein produced by prostate cells. PSA can be elevated for several reasons besides cancer, so the result needs context.
Read article →Benign enlargement, inflammation, infection, and some recent procedures may affect PSA levels. An elevated result is a signal to evaluate, not a cancer diagnosis.
Read article →PSA screening can help detect some cancers earlier but also leads to false positives, overdiagnosis, and potential treatment harms. Different guidelines weigh these benefits and harms differently.
Read article →The U.S. Preventive Services Task Force recommends an individual decision about PSA screening for men ages 55 to 69 and recommends against routine PSA screening for men age 70 and older. Other professional guidelines may differ.
Read article →The American Cancer Society encourages informed conversations about screening, with timing influenced by risk. Men at higher risk may need to begin that conversation earlier than average-risk men.
Read article →After an elevated PSA result, a clinician may repeat testing, review possible noncancer causes, consider additional blood or urine tests, or recommend imaging and biopsy depending on the situation.
Read article →A digital rectal exam allows a clinician to feel part of the prostate for abnormalities. It cannot detect all cancers and is not a substitute for a thoughtful screening discussion.
Read article →Multiparametric MRI can help identify suspicious areas and guide decisions about prostate biopsy. Its role depends on the clinical scenario, and a normal MRI does not eliminate all risk.
Read article →A prostate biopsy removes small tissue samples so a pathologist can examine them for cancer. Different approaches have distinct infection, bleeding, and sampling considerations.
Read article →Biopsies may sample the prostate through the skin between the scrotum and anus or through the rectum. Clinicians choose an approach based on equipment, expertise, and infection-risk considerations.
Read article →Pathologists use patterns of cancer cells to describe how aggressive a prostate tumor appears. Gleason scoring contributes to risk classification but is interpreted with PSA, stage, and imaging.
Read article →Grade Groups 1 through 5 summarize prostate cancer pathology and help communicate aggressiveness. A higher group generally indicates more concerning cell patterns, but it does not alone determine treatment.
Read article →Prostate cancer stage describes where disease is found: within the prostate, nearby structures or lymph nodes, or distant sites. Stage helps guide management alongside grade and patient preferences.
Read article →Clinicians combine PSA, Grade Group, clinical stage, and sometimes other findings to estimate whether cancer is low, intermediate, or high risk. Risk grouping helps compare treatment choices.
Read article →A diagnosis can feel overwhelming, and appointments may contain unfamiliar terminology. A written list of questions about grade, stage, options, side effects, and follow-up can help.
Read article →Active surveillance monitors selected localized prostate cancers with scheduled testing instead of immediate treatment. It aims to avoid or delay side effects while detecting signs of progression.
Read article →Active surveillance seeks to monitor for changes that might prompt curative treatment. Watchful waiting generally focuses on symptoms and quality of life rather than frequent testing.
Read article →Radical prostatectomy removes the prostate gland and is one treatment option for selected localized cancers. Potential effects include urinary and sexual changes, and recovery varies.
Read article →Radiation therapy can treat localized or more advanced prostate cancer, sometimes alongside hormone therapy. Techniques and schedules differ based on risk and treatment goals.
Read article →External beam radiation directs treatment toward the prostate from outside the body. Planning aims to treat cancer while limiting exposure to nearby organs, but side effects remain possible.
Read article →Brachytherapy places radiation sources within or near the prostate and may be used for selected patients. Eligibility depends on cancer features, urinary function, and treatment planning.
Read article →Androgen deprivation therapy lowers or blocks testosterone signals that can fuel prostate cancer growth. It may be combined with radiation or used in advanced disease and can cause significant side effects.
Read article →Chemotherapy may be considered for certain advanced prostate cancers, often alongside other systemic treatments. Whether it is appropriate depends on disease characteristics and overall health.
Read article →Some advanced prostate cancers have molecular features that may inform targeted treatment choices. Tumor testing and inherited genetic testing answer different questions and may both be considered.
Read article →Immunotherapy has a role in selected prostate cancer settings, but it is not a universal treatment for every patient. Eligibility can depend on disease stage and tumor characteristics.
Read article →Radiopharmaceutical treatments deliver radiation through substances that travel in the body and target certain cancer-related features. They are used in specific advanced disease settings.
Read article →PSMA PET imaging can help locate prostate cancer in selected staging or recurrence situations. It is not automatically needed for everyone and may not detect microscopic disease.
Read article →Urinary leakage, urgency, or irritation may occur after prostate cancer treatment, depending on the approach. Symptoms can improve, and rehabilitation or other treatments may help.
Read article →Prostate cancer and its treatments may affect erections, libido, and intimacy. These effects are common topics in survivorship care and deserve respectful, practical discussion.
Read article →Fatigue can arise from cancer, disrupted sleep, emotional stress, or treatment. Its causes vary, and new or severe fatigue should be evaluated.
Read article →Long-term androgen deprivation can contribute to bone loss. Clinicians may recommend assessment and individualized strategies to reduce fracture risk.
Read article →Appropriate physical activity can support strength, function, and well-being during cancer care. The safest plan depends on treatment, symptoms, and other medical conditions.
Read article →A balanced eating pattern can support overall health, but no single food or supplement has been shown to cure prostate cancer. Treatment-related nutrition needs may vary.
Read article →Supplements marketed for prostate health can interact with medicines or have uncertain benefits. Large doses of some nutrients may cause harm, and marketing claims often exceed evidence.
Read article →Avoiding tobacco and following evidence-based guidance about alcohol can support general health. These steps are not a guarantee against prostate cancer but may benefit long-term well-being.
Read article →Fear, uncertainty, and sadness are common after diagnosis or during treatment. Counseling, support groups, and conversations with loved ones can help people cope.
Read article →Partners often help with appointments, information gathering, and emotional support. Respecting the patient's preferences and sharing responsibilities can reduce strain.
Read article →Caregiving can affect sleep, work, finances, and emotional health. Taking breaks and asking for help are practical ways to maintain the ability to care for someone else.
Read article →Age-appropriate, truthful conversations can help children understand changes at home. Families may benefit from guidance from oncology social workers or counselors.
Read article →Appointments are often brief and information-heavy. Notes about symptoms, medicines, questions, and goals can make visits more productive.
Read article →A second opinion can help clarify diagnosis, risk classification, and treatment options. It may be particularly useful when several reasonable approaches have different tradeoffs.
Read article →Clinical trials evaluate ways to prevent, detect, or treat disease. Participation is voluntary and eligibility depends on the trial's specific criteria.
Read article →A study headline may describe early results, a small population, or an association rather than a proven benefit. Study design and publication context matter.
Read article →Researchers are studying AI tools for imaging, pathology, and risk assessment. Such tools can support clinicians but require validation and should not replace individualized medical judgment.
Read article →After some treatments, a rising PSA can suggest recurrence, but thresholds differ by treatment type. A change in PSA does not automatically identify where disease is located.
Read article →Follow-up plans commonly include PSA testing, symptom assessment, and management of late effects. Timing depends on treatment and disease risk.
Read article →Advanced prostate cancer may require long-term treatment and supportive care. Goals can include slowing disease, relieving symptoms, and protecting quality of life.
Read article →Palliative care focuses on symptom relief, communication, and quality of life and can be provided alongside cancer treatment. Hospice has different eligibility and goals.
Read article →Cancer care may involve costs for tests, treatments, travel, and time away from work. Oncology social workers and financial navigators can help identify available resources.
Read article →Transportation, insurance, paid leave, language, and trust can affect whether people receive timely screening discussions and follow-up. Community partnerships can reduce practical barriers.
Read article →Health fairs can create opportunities for education and referrals, but they should not substitute for a sustained relationship with a healthcare professional.
Read article →A respectful conversation about risk and screening may be more helpful than pressuring someone into a test. Screening decisions involve individual values and potential harms.
Read article →September is recognized as Prostate Cancer Awareness Month. Campaigns can highlight disparities, encourage questions about risk, and connect communities with reliable resources.
Read article →Blue is widely used in prostate cancer awareness campaigns. Symbols can spark conversations, but useful outreach also includes trustworthy health information and practical next steps.
Read article →Kevin Byrd and Blossom Brown established the Brown Byrd Foundation in 2008 after losing their grandfathers to prostate cancer. Their mission centers on awareness, early detection education, and community advocacy.
Read article →The Foundation's founders created the short film The Last Dayz to tell the story of a young man facing a prostate cancer diagnosis. Storytelling can make difficult health conversations more approachable.
Read article →The Foundation describes participating in health fairs, student forums, and screening awareness activities with community partners. Education and partnership are central to its mission.
Read article →The Foundation's history includes civic recognition and media coverage of its advocacy. Public recognition can amplify health messages when paired with accurate, actionable information.
Read article →The Foundation's original blog also addressed breast cancer awareness. Breast and prostate cancer family histories can sometimes intersect through inherited genetic variants, making complete family histories valuable.
Read article →Medical information online varies in quality. Government cancer institutes, major professional organizations, and your own care team are useful starting points for evidence-based answers.
Read article →Try another keyword or choose All topics.
These articles provide general education, not personalized medical advice. Screening guidelines differ by organization and individual risk. The collection was assembled with 2026 statistics and links to medical authorities; articles are not presented as original medical research.
The Brown Byrd Foundation's original blog emphasized prostate cancer awareness, breast cancer awareness, and the founders' personal motivation for advocacy. These themes remain at the heart of the expanded educational library.
Learn more about the Foundation and support community health education.
